Analysts/Institutional Investor Meet/Con. Call Updates

Concord Biotech Limited has informed the exchanges about its upcoming schedule for an Analyst/Institutional Investor meet. The company's officials will participate in a Non-Deal Roadshow (NDR) to engage with investors. This outreach allows the company to interact directly with the investment community, sharing insights into its operations and strategy. While no specific financial figures or immediate decisions were disclosed, such events help foster transparency and investor relations.